Low Dose Naltrexone – New Hope for Autoimmune Disease
Over recent years there has been a growing recognition that autoimmune diseases result from immunodeficiency, specifically a disturbance of the ability of the immune system to distinguish its “self” from “non-self”.
The result of this civil war within the body is many debilitating symptoms, but the experiences of individuals with autoimmune diseases who have begun a regime of low dose treatment with Naltrexone have been remarkable.
Patients with diagnoses as diverse HIV, lupus, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, ALS (Amyotrophic Lateral Sclerosis) and Crohn’s disease have all benefited.
In addition, people with fibromyalgia and chronic fatigue syndrome have had marked improvement using low dose naltrexone, suggesting that these conditions also have an autoimmune issue as well.
The greatest numbers of patients (some 400) treated with Naltrexone are those suffering from multiple sclerosis, to date less than 1% of these patients has ever experienced a fresh attack of MS whilst they have maintained their regular low dose Naltrexone nightly therapy.
Source: IAS Newsletter [firstname.lastname@example.org]